Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems.

Neuropharmacology

Unité de recherche en Neuroscience, Le Centre Hospitalier Universitaire de Québec, Pavillon CHUL, 2705 Boulevard Laurier, Sainte-Foy, Quebec G1V 4G2, Canada.

Published: December 2003

The pathogenesis of levodopa-induced dyskinesias (LID) still remains obscure. It has been suggested that enhanced opioidergic transmission in striatal output pathways may play a role in the induction of LID. To test this hypothesis, we have investigated the effect of different doses of the opioid receptor antagonists, naloxone and naltrexone on the dyskinetic response to a D1 agonist SKF 82958, a D2 agonist quinpirole and L-3,4-dihydroxyphenylalanine (L-Dopa). We have used six female cynomolgus monkeys rendered parkinsonian by the toxin MPTP and presenting a stable parkinsonian syndrome. All responded to L-Dopa and had developed dyskinesias which were manifested with each dose. The parkinsonian syndrome and dyskinesias were evaluated for each animal and scored after the treatments. Locomotor activity was measured by an electronic motility monitoring system. Our results show that coadministration of naloxone or naltrexone with dopaminergic agents leads to a significant increase in the severity of dyskinesias without noticeable effect on the antiparkinsonian efficacy of the treatment. These results suggest that increased opioidergic transmission in the two major striatal output pathways in monkeys or humans with LID might be an attempt to dampen the effect of abnormal dopaminergic stimulation rather than the cause of dyskinesias.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0028-3908(03)00249-1DOI Listing

Publication Analysis

Top Keywords

dyskinetic response
8
dopaminergic agents
8
opioidergic transmission
8
striatal output
8
output pathways
8
naloxone naltrexone
8
parkinsonian syndrome
8
dyskinesias
5
opioid antagonists
4
antagonists increase
4

Similar Publications

Learning ballet technique modulates the stretch reflex in students with cerebral palsy: case series.

BMC Neurosci

November 2024

School of Physical and Occupational Therapy, Faculty of Medicine and Health Sciences, McGill University, 3654 Prom Sir-William-Osler Street, Montreal, QC, H3G 1Y5, Canada.

Background: Cerebral palsy (CP) is considered the most prevalent developmental motor disorder in children. There is a need for training programs that enhance motor abilities and normalize function from an early age. Previous studies report improved motor outcomes in dance interventions for CP.

View Article and Find Full Text PDF

An intensive eye-tracking intervention in children with dyskinetic cerebral palsy: a multiple case study.

Disabil Rehabil Assist Technol

October 2024

Department of Rehabilitation Sciences, Neurorehabilitation Technology Lab, KU Leuven, Bruges, Belgium.

Article Synopsis
  • - The study investigated a four-week eye-tracking intervention for children with dyskinetic cerebral palsy, focusing on goal achievement, communication skills, stress levels, and caregivers' perspectives.
  • - Three children participated, and methods included measuring personal goals with the Goal Attainment Scale and assessing communication using specialized tools, alongside monitoring stress through heart rate variability.
  • - Results showed all participants achieved their eye-tracking goals and maintained communication improvements over six months, indicating the intervention's effectiveness regardless of individual differences, while highlighting the need for future research improvements.
View Article and Find Full Text PDF

Targeting serum response factor (SRF) deactivates ΔFosB and mitigates Levodopa-induced dyskinesia in a mouse model of Parkinson's disease.

Gene Ther

November 2024

Xuzhou Key Laboratory of Neurobiology, Department of Neurobiology and Anatomy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, Jiangsu, 221004, China.

Article Synopsis
  • L-DOPA is the main treatment for Parkinson's Disease but can cause involuntary movements known as Levodopa-induced dyskinesia (LID) over time.
  • The study reveals that the protein serum response factor (SRF) activates the FosB gene, leading to increased dyskinetic movements in a mouse model of Parkinson's treated with L-DOPA.
  • Knocking down SRF reduced involuntary movements, while overexpressing it worsened LID; additionally, the Akt signaling pathway was found to play a significant regulatory role in this process.
View Article and Find Full Text PDF

Altered interaction between striatonigral dopaminergic (DA) inputs and local acetylcholine (ACh) in striatum has long been hypothesized to play a central role in the pathophysiology of dystonia and dyskinesia. Indeed, previous research using several genetic mouse models of human isolated dystonia identified a shared endophenotype with paradoxical excitation of striatal cholinergic interneuron (ChIs) activity in response to activation of dopamine D2 receptors (D2R). These mouse models lack a dystonic motor phenotype, which leaves a critical gap in comprehending the role of DA and ACh transmission in the manifestations of dystonia.

View Article and Find Full Text PDF

New-onset hydrocephalus in an adult with cerebral palsy: A case report and review of the literature.

J Pediatr Rehabil Med

September 2024

Department of Physical Medicine & Rehabilitation, Children's Hospital Colorado, University of Colorado Anschutz, Aurora, CO, USA.

Article Synopsis
  • - Hydrocephalus is often found alongside brain injuries like cerebral palsy (CP) and can appear in early childhood; however, adult-onset hydrocephalus can also occur, as shown in a mid-20s patient with CP.
  • - The patient experienced new leg spasms and tried various treatments with no success, leading to MRI imaging which revealed significant ventriculomegaly and elevated pressure through a lumbar puncture.
  • - Following the placement of a ventriculoperitoneal shunt, the patient's symptoms dramatically improved, emphasizing the need for ongoing monitoring and research on the risk of hydrocephalus in adults with CP.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!